Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Liquidia Corporation

LQDA
16,11
-0,39 (-2,36%)
22 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/2/202523:34EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
23/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202522:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202522:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202514:00GLOBELiquidia Corporation to Present at 43rd Annual J.P. Morgan..
04/12/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202412:45EDGAR2Form 8-K - Current report
13/11/202412:30GLOBELiquidia Corporation Reports Third Quarter 2024 Financial..
12/11/202414:00GLOBELiquidia to Present at the Stifel 2024 Healthcare Conference
06/11/202414:00GLOBELiquidia Corporation to Report Third Quarter 2024 Financial..
04/11/202414:00GLOBELiquidia Corporation to Report Third Quarter 2024 Financial..
22/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202421:31EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
16/10/202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202416:00GLOBEUnited States Supreme Court Declines to Review Rulings that..
02/10/202412:00GLOBELiquidia and Pharmosa Biopharm Expand Collaboration to..
30/9/202414:00GLOBELiquidia Announces Poster Presentation and Medical Theater..
17/9/202423:15EDGAR2Form 8-K - Current report
16/9/202415:41GLOBECourt Finds United Therapeutics’ Interference with Launch of..
12/9/202422:01EDGAR2Form 8-K - Current report
11/9/202422:41EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
11/9/202414:33EDGAR2Form 8-K - Current report
11/9/202414:29EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
11/9/202414:26GLOBELiquidia Corporation Announces Raise of $67.5 Million from..
11/9/202414:08EDGAR2Form 8-K - Current report
04/9/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202414:00GLOBELiquidia to Present at Upcoming Investor Conferences
22/8/202412:31EDGAR2Form 8-K - Current report
22/8/202412:00GLOBELiquidia Files Litigation to Challenge Regulatory..
19/8/202413:00EDGAR2Form 8-K - Current report
19/8/202412:00GLOBEU.S. FDA Grants Tentative Approval of YUTREPIA™..
16/8/202412:30GLOBELiquidia Announces Poster Presentations at the PHA 2024..
07/8/202413:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:00EDGAR2Form 8-K - Current report
07/8/202412:30GLOBELiquidia Corporation Reports Second Quarter 2024 Financial..
31/7/202414:00GLOBELiquidia Corporation to Report Second Quarter 2024 Financial..
22/7/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202414:42GLOBELiquidia Announces Poster Presentations at the 7th World..
05/6/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202413:30EDGAR2Form 8-K - Current report
03/6/202413:00GLOBEDistrict Court Issues Favorable Ruling and Denies United..
Apertura: 16,72 Min: 16,10 Max: 16,7384
Chiusura: 16,50

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network